As part of ManhattanLife's ongoing commitment to providing meaningful, high-value supplemental coverage, we will sunset our Cancer First Occurrence Benefit product effective February 1, 2026. Existing policies will remain in force as long as premiums continue to be paid.

The transition allows us to focus on stronger, more flexible solutions including our Cancer and/or Heart Attack & Stroke, Cancer Care Plus and Critical Protection and Recovery products.

ManhattanLife Critical Illness and Cancer Products

Our Cancer and/or Heart Attack & Stroke product delivers customizable protection with combined lump sum benefits of up to $150,000, giving customers the ability to choose Cancer coverage only, Heart & Stroke coverage only or a combination of both. Optional riders, including a Cancer Recurrence Rider and Heart and Stroke Restoration Rider, provide additional value and peace of mind.

Cancer Care Plus provides coverage for expenses related to cancer and other specified diseases, including muscular dystrophy, epilepsy, meningitis and multiple sclerosis. Benefits include hospital care, treatment-related services and other covered expenses, along with a First Occurrence Benefit, with optional riders available to enhance coverage.

The Critical Protection and Recovery product offers coverage for expenses related to serious critical illnesses such as heart attack, stroke and other life-altering events. Benefits include hospital care, income-related support and other covered services. Optional coverage is available to further expand protection.

This update reflects our focus on delivering better overall value while continuing to support policyholders for every stage of life.